Skip to content
aiqbench takeAI Products

aiqbench analysis

This narrative review synthesizes the current state of machine learning applications in cardiac amyloidosis, highlighting a maturity gradient where AI-assisted interpretation of cardiac scintigraphy is most advanced. The analysis underscores that while deep learning models effectively handle specific imaging tasks like SPECT/CT quantification, comprehensive patient diagnosis still necessitates integration with clinical context and traditional biomarker testing. Consequently, the primary focus remains on refining multimodal clinical workflows rather than advancing fundamental algorithmic theory.
Source coveringarXiv
What this isA model's reading of the article and related coverage, written for aiqbench. Not the publisher's words.

Artificial Intelligence Across the Cardiac Amyloidosis Diagnostic and Management Pathway: From Single-Modality Detection to Multimodal Clinical Integration

arXiv2 min read

arXiv:2607.09948v2 Announce Type: replace-cross Abstract: Cardiac amyloidosis (CA) is increasingly recognized but remains substantially underdiagnosed because its clinical and imaging phenotype overlaps with more common cardiomyopathies. Definitive subtype assignment and management further require integration of multimodal evidence to distinguish transthyretin from light-chain disease. Machine learning and deep learning have been applied across the diagnostic and management pathway. These applications span electrocardiography (ECG), echocardiography, and health record-based case finding, as well as cardiac magnetic resonance (CMR) and nuclear interpretation, including single-photon emission computed tomography/computed tomography (SPECT/CT) biomarker quantification, prognostic modeling, and treatment response assessment. This narrative review synthesizes these studies by clinical tasks, namely screening, detection, quantification, prognosis, and longitudinal assessment after treatment initiation, rather than by input modality. This task-based organization clarifies why apparently similar AI models require different cohorts, reference standards, evaluation metrics, and implementation thresholds. The evidence reveals a maturity gradient. Binary detection and AI-assisted interpretation of cardiac scintigraphy with bone-avid tracers and SPECT/CT currently represent one of the more mature AI applications in cardiac amyloidosis, supporting standardized image interpretation and quantitative biomarker extraction. However, patient-level diagnosis still requires integration with monoclonal protein testing, SPECT/CT localization, clinical context, and biopsy or tissue typing when indicated.

Abstract:Cardiac amyloidosis (CA) is increasingly recognized but remains substantially underdiagnosed because its clinical and imaging phenotype overlaps with more common cardiomyopathies. Definitive subtype assignment and management further require integration of multimodal evidence to distinguish transthyretin from light-chain disease. Machine learning and deep learning have been applied across the diagnostic and management pathway. These applications span electrocardiography (ECG), echocardiography, and health record-based case finding, as well as cardiac magnetic resonance (CMR) and nuclear interpretation, including single-photon emission computed tomography/computed tomography (SPECT/CT) biomarker quantification, prognostic modeling, and treatment response assessment. This narrative review synthesizes these studies by clinical tasks, namely screening, detection, quantification, prognosis, and longitudinal assessment after treatment initiation, rather than by input modality. This task-based organization clarifies why apparently similar AI models require different cohorts, reference standards, evaluation metrics, and implementation thresholds. The evidence reveals a maturity gradient. Binary detection and AI-assisted interpretation of cardiac scintigraphy with bone-avid tracers and SPECT/CT currently represent one of the more mature AI applications in cardiac amyloidosis, supporting standardized image interpretation and quantitative biomarker extraction. However, patient-level diagnosis still requires integration with monoclonal protein testing, SPECT/CT localization, clinical context, and biopsy or tissue typing when indicated.

Diana Shadibaeva and Rochak Dhakal contributed equally to this work. Total Pages = 35, No. of Figures = 4, No. of Tables on Manuscript = 1, Supplementary Tables = 6

Medical Physics (physics.med-ph); Machine Learning (cs.LG)

arXiv:2607.09948 [physics.med-ph]

(or arXiv:2607.09948v2 [physics.med-ph] for this version)

Full text under the publisher's open licence · 236 words

Related coverage